Regent Pacific Group Limited (HKG:0575)

Hong Kong · Delayed Price · Currency is HKD

0.6100

-0.0200 (-3.17%)

Apr 24, 2026, 3:27 PM HKT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biopharma	363.00K	719.00K	291.00K	114.00K	3.25M
Biopharma Growth	-49.51%	147.08%	155.26%	-96.50%	168.48%
Total	363.00K	719.00K	291.00K	114.00K	3.25M
Total Growth	-49.51%	147.08%	155.26%	-96.50%	168.48%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Europe	267.00K	165.00K	243.00K	61.00K	54.00K
Europe Growth	61.82%	-32.10%	298.36%	12.96%	-51.79%
United States	9.00K	18.00K	35.00K	29.00K	-
United States Growth	-50.00%	-48.57%	20.69%	-	-
Asia Pacific	87.00K	536.00K	13.00K	24.00K	-
Asia Pacific Growth	-83.77%	4023.08%	-45.83%	-	-
China	-	-	-	-	3.20M
China Growth	-	-	-	-	300.00%
Total	363.00K	719.00K	291.00K	114.00K	3.25M
Total Growth	-49.51%	147.08%	155.26%	-96.50%	168.48%

Source: S&P Global Market Intelligence.